Kodiak Sciences shares more than doubled after Zenkuda and KSI-501 met their primary goal in a Phase 3 wet AMD study. The company plans to file for regulatory approval in Q4.
One free account opens every story complete, the live board, the 30-day calendar, a watchlist and breaking alerts on your phone. No card. The wire stays free to read.
